Deferred Tax Assets, Valuation Allowance of Autolus Therapeutics plc from 30 Sep 2017 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Autolus Therapeutics plc quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 30 Sep 2017 to 31 Dec 2024.
  • Autolus Therapeutics plc Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $156,997,000, a 28% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Autolus Therapeutics plc Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $156,997,000 +$34,039,000 +28% 31 Dec 2024 10-K 20 Mar 2025 2024 FY
Q4 2023 $122,958,000 +$27,003,000 +28% 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q4 2022 $95,955,000 +$10,451,000 +12% 31 Dec 2022 10-K 20 Mar 2025 2024 FY
Q4 2021 $85,504,000 +$28,968,000 +51% 31 Dec 2021 20-F 07 Mar 2023 2022 FY
Q4 2020 $56,536,000 +$34,904,000 +161% 31 Dec 2020 20-F 10 Mar 2022 2021 FY
Q4 2019 $21,632,000 +$10,290,000 +91% 31 Dec 2019 20-F 04 Mar 2021 2020 FY
Q4 2018 $11,342,000 31 Dec 2018 20-F 03 Mar 2020 2019 FY
Q3 2018 $10,040,000 +$5,053,000 +101% 30 Sep 2018 20-F 25 Feb 2019 2019 Q1
Q3 2017 $4,987,000 30 Sep 2017 20-F 25 Feb 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.